Found 103 matching trials
Study of the Role of Innate Lymphoid Cells and Natural Killer Cells in Immune Activation of Vitiligo - INNATE Vitiligo N/A The cohort included only major patients with non-segmental vitiligo and no ...
Show More Learn More & Join Trial
Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia PHASE1 The purpose of this study is to evaluate safety, feasibility and maximum to...
Show More Location
Centro Terapia e Tecnologia Celular
Learn More & Join Trial
Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation PHASE1 Ayurvedic medicine has been practiced in for more than 2,500 years. Ashwaga...
Show More Location
Helfgott Research Institute
Learn More & Join Trial
Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy PHASE2 In this study, participants with high-risk hematologic malignancies undergo...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells PHASE1 This study will analyze and evaluate the following items:
1. The safety of...
Show More Learn More & Join Trial
Immunotherapy Before and After Surgery PHASE2 This Phase 2 clinical trial is testing a new immunotherapy combination (N-8...
Show More Location
Multiple Locations
Learn More & Join Trial
"LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia PHASE2 To determine safety profile of immunotherapy with natural killer cells and ...
Show More Location
Hospital 12 de Octubre
Learn More & Join Trial
NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS PHASE1 This is a single-arm, open-label, multi-center, Phase 1 study to determine ...
Show More Status
Active Not Recruiting
Location
Colorado Blood Cancer Institute
Learn More & Join Trial
A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML PHASE1 INMB-INB16-002 is a Phase I open-label, dose escalation study of INKmune th...
Show More Location
Attikon University General Hospital
Learn More & Join Trial
Biological Analysis of MABs in NHL in a Translational Prospective Observational Study Within Italian Clinical Practice N/A This a prospective, multicenter, observational pharmacological translationa...
Show More Location
Ematologia - Fondazione del Piemonte per l'Oncologia - IRCCS
Learn More & Join Trial